acitretin has been researched along with Lymphoma, T-Cell, Cutaneous in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Aquino, C; Avallone, G; Boskovic, S; Fava, P; Macagno, N; Quaglino, P; Ribero, S; Roccuzzo, G | 1 |
Hartman, R; Meehan, S; Pomeranz, MK; Sanchez, M; Sanders, SE; Tran, K; Tzu, J | 1 |
Cheeley, J; DeLong, LK; Parker, SR; Sahn, RE | 1 |
Exadaktylou, D; Hatziolou, E; Kontochristopoulos, GJ; Tassidou, A; Zakopoulou, N | 1 |
French, LE; Saurat, JH | 1 |
Bagot, M | 1 |
French, LE; Ramelet, AA; Saurat, JH | 1 |
Burg, G; Dummer, R; Joller-Jemelka, HI; Prümmer, O; Rajan, GP; Seifert, B | 1 |
Henz, BM; Kühl, P; Luger, T; Otte, HG; Stadler, R; Sterry, W; Zwingers, T | 1 |
Burmester, GR; Dörner, T; Feist, E; Hiepe, F; Lukowsky, A; Stroehmann, A | 1 |
1 trial(s) available for acitretin and Lymphoma, T-Cell, Cutaneous
Article | Year |
---|---|
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lymph Nodes; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Prospective Studies; PUVA Therapy; Recombinant Proteins; Remission Induction; Skin Neoplasms; Treatment Outcome | 1998 |
9 other study(ies) available for acitretin and Lymphoma, T-Cell, Cutaneous
Article | Year |
---|---|
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin.
Topics: Acitretin; Anticarcinogenic Agents; Bexarotene; Humans; Lymphoma, T-Cell, Cutaneous; Retrospective Studies; Skin Neoplasms; Tetrahydronaphthalenes | 2022 |
Photolichenoid plaques with associated vitiliginous pigmentary changes.
Topics: Acitretin; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bacteremia; Diagnosis, Differential; Disease Progression; Eczema; Erythema; Glucocorticoids; Herpes Simplex; Humans; Lichenoid Eruptions; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Middle Aged; Photosensitivity Disorders; Pseudolymphoma; Trimethoprim, Sulfamethoxazole Drug Combination; Ultraviolet Therapy; Vitiligo | 2011 |
Acitretin for the treatment of cutaneous T-cell lymphoma.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Bexarotene; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2013 |
Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin.
Topics: Acitretin; Adult; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon-alpha; Keratolytic Agents; Lymphoma, T-Cell, Cutaneous; Mucinosis, Follicular; Paraneoplastic Syndromes; Recombinant Proteins | 2001 |
Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
Topics: Acitretin; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Humans; Isotretinoin; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Remission Induction; Skin Neoplasms | 1995 |
Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
Topics: Acitretin; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms; Treatment Outcome | 1995 |
Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin.
Topics: Acitretin; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Humans; Lymphoma, T-Cell, Cutaneous; Remission Induction; Skin Neoplasms | 1994 |
Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA.
Topics: Acitretin; Aged; Antibodies; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; PUVA Therapy; Recombinant Proteins; Retrospective Studies | 1996 |
Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjögren's syndrome.
Topics: Acitretin; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; Liver Cirrhosis, Biliary; Lymphoma, T-Cell, Cutaneous; Middle Aged; Mycosis Fungoides; PUVA Therapy; Sjogren's Syndrome; Skin Neoplasms; Treatment Outcome | 2002 |